Integrating Multimorbidity into a Whole-Body Understanding of Disease Using Spatial Genomics
Multimorbidity is characterized by multidimensional complexity emerging from interactions between multiple diseases across levels of biological (including genetic) and environmental determinants and the complex array of interactions between and within cells, tissues and organ systems. Advances in spatial genomic research have led to an unprecedented expansion in our ability to link alterations in genome folding with changes that are associated with human disease. Studying disease-associated genetic variants in the context of the spatial genome has enabled the discovery of transcriptional regulatory programmes that potentially link dysregulated genes to disease development. However, the approaches that have been used have typically been applied to uncover pathological molecular mechanisms occurring in a specific disease-relevant tissue. These forms of reductionist, targeted investigations are not appropriate for the molecular dissection of multimorbidity that typically involves contributions from multiple tissues. In this perspective, we emphasize the importance of a whole-body understanding of multimorbidity and discuss how spatial genomics, when integrated with additional omic datasets, could provide novel insights into the molecular underpinnings of multimorbidity.
|ISBN||0080-1844 (Print) 0080-1844 (Linking)|
|Authors||Gokuladhas, S.; Zaied, R. E.; Schierding, W.; Farrow, S.; Fadason, T.; O'Sullivan, J. M.|
|Publisher Name||Results Probl Cell Differ|
|URL link to publisher's version||https://www.ncbi.nlm.nih.gov/pubmed/36348107|